We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+2.7%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$746M
AUM Growth
-$106M
Cap. Flow
-$67.1M
Cap. Flow %
-9%
Top 10 Hldgs %
44.28%
Holding
510
New
122
Increased
34
Reduced
59
Closed
238

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$49.5M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$21.8M
3
DIS icon
Walt Disney
DIS
+$16.1M
4
MSFT icon
Microsoft
MSFT
+$11M
5
TSM icon
TSMC
TSM
+$8.27M

Top Sells

Rank Stock Value
1
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$6.55M
2
BHC icon
Bausch Health
BHC
+$5.35M
3
DLR icon
Digital Realty Trust
DLR
+$1.95M
4
PFSI icon
PennyMac Financial
PFSI
+$1.67M
5
COP icon
ConocoPhillips
COP
+$1.62M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 7.31%
2 Communication Services 4.95%
3 Technology 3.75%
4 Energy 1.57%
5 Healthcare 1.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
401
PUT
Procter & Gamble
PG
$340B
– –
-7,200
Closed -$1.03M
PLAY icon
402
PUT
Dave & Buster's
PLAY
$357M
– –
-20,000
Closed -$656K
PM icon
403
CALL
Philip Morris
PM
$309B
– –
-99,500
Closed -$9.82M
PPC icon
404
CALL
Pilgrim's Pride
PPC
$7.13B
– –
-700
Closed -$22K
PPC icon
405
Pilgrim's Pride
PPC
$7.13B
– –
-4,500
Closed -$141K
PRG icon
406
CALL
PROG Holdings
PRG
$1.71B
– –
-31,200
Closed -$515K
PRGO icon
407
CALL
Perrigo
PRGO
$1.44B
– –
-24,000
Closed -$974K
PTGX icon
408
CALL
Protagonist Therapeutics
PTGX
$8.55B
– –
-128,000
Closed -$1.01M
QGEN icon
409
Qiagen
QGEN
$8.62B
– –
-1,415
Closed -$71K
QNCX icon
410
CALL
Quince Therapeutics
QNCX
$21.5M
– –
-196
Closed -$87K
REMX icon
411
CALL
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.91B
– –
-8,000
Closed -$694K
RLAY icon
412
CALL
Relay Therapeutics
RLAY
$4B
– –
-3,000
Closed -$50K
RVLV icon
413
Revolve Group
RVLV
$1.85B
– –
-25,000
Closed -$648K
RVLV icon
414
PUT
Revolve Group
RVLV
$1.85B
– –
-28,000
Closed -$725K
SAGE
415
DELISTED
Sage Therapeutics
SAGE
– –
-16,000
Closed -$517K
SAGE
416
PUT
DELISTED
Sage Therapeutics
SAGE
– –
-52,500
Closed -$1.7M
FLNA
417
PUT
Filana Therapeutics
FLNA
$42M
– –
-31,000
Closed -$872K
SCHW
418
CALL
Charles Schwab
SCHW
$182B
– –
-1,000
Closed -$63K
SENS icon
419
CALL
Senseonics Holdings Inc
SENS
$254M
– –
-1,150
Closed -$24K
SGHC icon
420
CALL
SGHC Ltd
SGHC
$7.57B
– –
-45,000
Closed -$185K
SLB icon
421
CALL
SLB Ltd
SLB
$72.7B
– –
-37,100
Closed -$1.33M
SPGI icon
422
CALL
S&P Global
SPGI
$124B
– –
-90,500
Closed -$30.5M
SPGI icon
423
PUT
S&P Global
SPGI
$124B
– –
-500
Closed -$169K
SPY icon
424
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$771B
– –
-287,000
Closed -$108M
SRI icon
425
CALL
Stoneridge
SRI
$200M
– –
-10,000
Closed -$172K
15 16
17
18 19

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q3 2022 Portfolio in Review

As of Q3 2022, SG3 Management held 510 positions worth $746M, down 12% from $852M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

SG3 Management withdrew a net $67.1M in Q3 2022, closing 238 positions and reducing 59 holdings. Its most notable exit was KraneShares CSI China Internet ETF, an estimated $6.55M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 7.3% of assets, up from 0.21% a quarter earlier, followed by Communication Services and Technology.

Against the trend, SG3 Management opened a new position in Tesla worth $47M.

  • SG3 Management's largest Q3 2022 buy was Tesla: 177,200 shares worth $47M.
  • SG3 Management added most to Apellis Pharmaceuticals in Q3 2022, an estimated $2.3M increase.
  • SG3 Management's biggest Q3 2022 reduction was LivaNova, cutting an estimated $1.29M.
  • SG3 Management fully exited KraneShares CSI China Internet ETF in Q3 2022, selling an estimated $6.55M.
  • SG3 Management's ten largest holdings make up 44% of its $746M portfolio in Q3 2022.
  • SG3 Management opened 122 new positions and closed 238 in Q3 2022.
  • SG3 Management's portfolio value fell 12% quarter-over-quarter to $746M.

Based on SG3 Management's 13F filing for Q3 2022, filed 14 Nov 2022.